1Strehlau J, Pavlakis M, Lipman et al. Quantitative detection of immnune activation transcrips as a diagnostic tool in kidney transplantation. Proc Natl Acad Sci USA, 1997,94:695
2Lipman ML,Stevens AC,Strom TB. Heightened intragraft cytotoxic T lymphocyte gene expression in acutely rejecting renal allografts. J Immunol,1994,152:5120
3Vijay KS, Roxana MB, Li BB a al. Molecular executors of cell death-differential intrarenal expression of Fas ligand, Fas, granzyme B, and perforin during acute and/or chronic rejection of human renal allografts.Transplantation, 1996,62:1 860
4Schachter AD, Vasconcellos L, Ophascharoensuk V et al. CTL Effector Mechanisms: Diagnostic Applications. Transplantation Proc, 1998, 30(5): 2344
5Peter CW, Joke GB, Jolanda CL et al. Mechanism of lymphocyte-mediated cytotoxicity in acute renal allograft rejection. Transplantation, 1998,66(2): 259
6Lipman ML, Shen Y, Jeffery JR et al. Immune-activation gene expression in clinically stable renal allograft biopsies: molecular evidence for subclinical rejection. Transplantation, 1998, 66(12): 1 673
7Medley QG, Kedersha N,O'Brien S et al.Characterization of GMP -17,a ganule membrane protein that moves to the plasma membrane of natural killer cells following target cell recognition. Proc Natl Acad Sci USA,1996,93:685
8Shane MM,Robert TM,Manuel P et al.Cytotoxicity and apoptosis in human renal allografts: identification, distribution, and quantitation of cells with a cytotoxic granule protein GMP-17(TIA-1 ) and cells with fragmented nuclear DNA. Lab invest, 1997,76(5):639
9Lillian WG, Linda WM, Rita RA et al. Correlation between Banff classification,acute renal rejection scores and reversal of rejection. Kidney int,1996,49:481
10Rush DN, Henry SF, Jeffery JR et al . Histological fmding in early routine biopsies of stable renal allograft recipients. Transplantation, 1994,57(2): 208
